(4-溴-2-甲基苯基)肼结构式
|
常用名 | (4-溴-2-甲基苯基)肼 | 英文名 | 1-(4-Bromo-2-Methylphenyl)hydrazine, HCl |
|---|---|---|---|---|
| CAS号 | 56056-25-8 | 分子量 | 201.06400 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C7H9BrN2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (4-溴-2-甲基苯基)肼 |
|---|---|
| 英文名 | (4-bromo-2-methylphenyl)hydrazine |
| 英文别名 | 更多 |
| 分子式 | C7H9BrN2 |
|---|---|
| 分子量 | 201.06400 |
| 精确质量 | 199.99500 |
| PSA | 38.05000 |
| LogP | 2.81640 |
| InChIKey | VJTBVNWEWUHQOT-UHFFFAOYSA-N |
| SMILES | Cc1cc(Br)ccc1NN |
| 海关编码 | 2928000090 |
|---|
|
~82%
(4-溴-2-甲基苯基)肼 56056-25-8 |
| 文献:BAYER HEALTHCARE AG Patent: WO2004/5253 A1, 2004 ; Location in patent: Page/Page column 39; 40 ; WO 2004/005253 A1 |
|
~50%
(4-溴-2-甲基苯基)肼 56056-25-8 |
| 文献:Freeman-Cook, Kevin D.; Amor, Paul; Bader, Scott; Buzon, Leanne M.; Coffey, Steven B.; Corbett, Jeffrey W.; Dirico, Kenneth J.; Doran, Shawn D.; Elliott, Richard L.; Esler, William; Guzman-Perez, Angel; Henegar, Kevin E.; Houser, Janet A.; Jones, Christopher S.; Limberakis, Chris; Loomis, Katherine; McPherson, Kirk; Murdande, Sharad; Nelson, Kendra L.; Phillion, Dennis; Pierce, Betsy S.; Song, Wei; Sugarman, Eliot; Tapley, Susan; Tu, Meihua; Zhao, Zhengrong Journal of Medicinal Chemistry, 2012 , vol. 55, # 2 p. 935 - 942 |
|
~%
(4-溴-2-甲基苯基)肼 56056-25-8 |
| 文献:Michaelis,L. Chemische Berichte, 1893 , vol. 26, p. 2192 |
|
~%
(4-溴-2-甲基苯基)肼 56056-25-8 |
| 文献:Michaelis,L. Chemische Berichte, 1893 , vol. 26, p. 2192 |
| (4-溴-2-甲基苯基)肼上游产品 5 | |
|---|---|
| (4-溴-2-甲基苯基)肼下游产品 3 | |
| 海关编码 | 2928000090 |
|---|---|
| 中文概述 | 2928000090 其他肼(联氨)及胲(羟胺)的有机衍生物。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
| 2-Methyl-4-brom-phenylhydrazin |
| 5-Brom-2-hydrazino-toluol |
| 4-Brom-o-tolylhydrazin |